Amit Sachdev, EVP, Chief Patient Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,382 shares at $276.96 ($942K) on 2020-08-03, disclosed to the SEC on 2020-08-05.
Open-market sale of $942k VRTX by EVP, Chief Patient Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $276.96 | 500 | $138K | 14.7% |
| 2 | $278.25 | 690 | $192K | 20.4% |
| 3 | $278.25 | 690 | $192K | 20.4% |
| 4 | $279.18 | 751 | $210K | 22.3% |
| 5 | $279.18 | 751 | $210K | 22.3% |
| Total | $278.47 avg | 3,382 |
| $942K |
| 100% |
| Filing → |
| VRTX | SELL | 2024-05-17 | $14K | — | Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |